In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ayala Pharmaceuticals Inc.

www.ayalapharma.com

Latest From Ayala Pharmaceuticals Inc.

Venture Funding Deals: Takeda's Phathom Raises $140m In Crossover Round For GERD Program

AgomAb, CinCor and Confo Therapeutics secure Series A financing, while AlloVir closes a $121m Series B and more venture financing in April and May.

Deals Financing

Finance Watch: BIO Report Shows Record VC Funding Across Geographies

Private Company Edition: Venture capital for emerging therapeutics companies in the US and in ex-US regions reached all-time highs in 2018. Also, Alphamab raises $60m Series B, three new VC funds launch and FLX changes its name to RAPT.

Financing StartUps and SMEs

Big Year For Israeli Tissue Agnostic Company Ayala

The Rehovet-headquartered firm is looking to lead the way for the country's burgeoning biotech sector and take its gamma secretase inhibitors all the way through to Phase III.

Israel Companies

Israel Looks To Nurture New Leaders For Burgeoning Biotech Sector

While Israel has not wanted for early-stage scientific excellence, leading lights in the country's biotech space are working to create an ecosystem where clinical, regulatory and managerial expertise can develop.

Growth Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • Ayala Pharmaceuticals Inc.
  • Senior Management
  • Roni Mamluk, PhD, CEO
    Yossi Maimon, CFO
    Gary Gordon, MD, PhD, CMO
    Dana Gelbaum, SVP, Corp. Dev.
  • Contact Info
  • Ayala Pharmaceuticals Inc.
    Phone: 8-373-1541
    Oppenheimer 7
    Rehovot, 7670107
    Israel
Advertisement
Advertisement
UsernamePublicRestriction

Register